Osaic Holdings’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.9K Buy
3,120
+475
+18% +$1.8K ﹤0.01% 6564
2026
Q1
$10.2K Buy
2,645
+500
+23% +$1.97K ﹤0.01% 6278
2025
Q4
$8.43K Sell
2,145
-1,088
-34% -$4.81K ﹤0.01% 6444
2025
Q3
$13.7K Sell
3,233
-900
-22% -$3.26K ﹤0.01% 6169
2025
Q2
$12.9K Sell
4,133
-73
-2% -$235 ﹤0.01% 6006
2025
Q1
$14.2K Sell
4,206
-4,113
-49% -$19.2K ﹤0.01% 5589
2024
Q4
$47.2K Buy
8,319
+2,143
+35% +$13.8K ﹤0.01% 4751
2024
Q3
$36.1K Buy
6,176
+1,715
+38% +$12.5K ﹤0.01% 4969
2024
Q2
$35.3K Sell
4,461
-5,635
-56% -$47.2K ﹤0.01% 4948
2024
Q1
$94K Buy
10,096
+4,464
+79% +$37.7K ﹤0.01% 4298
2023
Q4
$47.5K Buy
5,632
+1,575
+39% +$11.4K ﹤0.01% 4945
2023
Q3
$31.4K Buy
4,057
+1,211
+43% +$11.1K ﹤0.01% 5293
2023
Q2
$32.6K Sell
2,846
-704
-20% -$7.28K ﹤0.01% 5235
2023
Q1
$27.4K Buy
3,550
+450
+15% +$3.58K ﹤0.01% 5375
2022
Q4
$19K Buy
3,100
+600
+24% +$3.41K ﹤0.01% 5611
2022
Q3
$15K Hold
2,500
﹤0.01% 5802
2022
Q2
$15K Sell
2,500
-500
-17% -$3.38K ﹤0.01% 5820
2022
Q1
$22K Buy
3,000
+1,500
+100% +$6.69K ﹤0.01% 5637
2021
Q4
$4K Buy
+1,500
New +$5.12K ﹤0.01% 6794
2020
Q3
Sell
-119
Closed -$2K 6427
2020
Q2
$2K Hold
119
﹤0.01% 5838
2020
Q1
$1K Buy
+119
New +$1.37K ﹤0.01% 5940

Other funds holding VYGR

Osaic Holdings's VYGR Position: Q2 2026 in Review

Osaic Holdings increased its Voyager Therapeutics (VYGR) stake by 18% in Q2 2026, buying an estimated $1.8K and bringing the position to 3,120 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6564.

Osaic Holdings first reported a position in VYGR in Q1 2020 and has held it in 21 quarters since. The position peaked at $94K in Q1 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Osaic Holdings held 3,120 shares of Voyager Therapeutics worth $10.9K as of Q2 2026.
  • Osaic Holdings bought 475 Voyager Therapeutics shares in Q2 2026, an estimated $1.8K.
  • Voyager Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6564 holding.
  • Osaic Holdings first reported a position in Voyager Therapeutics in Q1 2020 and has held it in 21 quarters since.
  • Osaic Holdings's Voyager Therapeutics position peaked at $94K in Q1 2024.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.